trending Market Intelligence /marketintelligence/en/news-insights/trending/lH9QgyY_nSfDTwW-o2lgWw2 content esgSubNav
In This List

Microbot Medical closes $10M stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Microbot Medical closes $10M stock offering

Microbot Medical Inc. closed a registered direct offering of 3,750,000 common shares for gross proceeds of $10.1 million.

The company will use the proceeds for its ViRob and TipCAT technology platforms, potential partnerships, and acquisitions and general corporate and working capital purposes.

Ladenburg Thalmann & Co. Inc. acted as the lead placement agent, while Chardan acted as the co-placement agent of the offering.